<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Oncohematology</journal-id><journal-title-group><journal-title xml:lang="en">Oncohematology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкогематология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1818-8346</issn><issn publication-format="electronic">2413-4023</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">614</article-id><article-id pub-id-type="doi">10.17650/1818-8346-2007-0-1-24-30</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>RARE AND DIFFICULT HEMATOLOGIC SYNDROMES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>РЕДКИЕ И СЛОЖНЫЕ ГЕМАТОЛОГИЧЕСКИЕ СИНДРОМЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Paraneoplastic pemphigus - a rare autoimmune complication in patients with chronic lymphocytic leukemia</article-title><trans-title-group xml:lang="ru"><trans-title>Паранеопластическая пузырчатка — редкое аутоиммунное осложнение при хроническом лимфолейкозе</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Volkova</surname><given-names>M. A.</given-names></name><name xml:lang="ru"><surname>Волкова</surname><given-names>М. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kitchigina</surname><given-names>M. Yu.</given-names></name><name xml:lang="ru"><surname>Кичигина</surname><given-names>М. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Potekaev</surname><given-names>N. S.</given-names></name><name xml:lang="ru"><surname>Потекаев</surname><given-names>Н. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Teplyuk</surname><given-names>N. P.</given-names></name><name xml:lang="ru"><surname>Теплюк</surname><given-names>Н. П.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kupriyanova</surname><given-names>A. G.</given-names></name><name xml:lang="ru"><surname>Куприянова</surname><given-names>А. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Blokhin Russian Cancer Research Centre, Russian Academy of Medical Sciences</institution></aff><aff><institution xml:lang="ru">РОНЦ им. Н.Н. Блохина, РАМН</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">I.M. Sechenov Moscow Medical Academy</institution></aff><aff><institution xml:lang="ru">ММА им. И.М.Сеченова</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">National Research Institute of Transplantology and Artificial Organs</institution></aff><aff><institution xml:lang="ru">НИИ трансплантологии и искусственных органов</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2007-02-22" publication-format="electronic"><day>22</day><month>02</month><year>2007</year></pub-date><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>24</fpage><lpage>30</lpage><history><date date-type="received" iso-8601-date="2022-11-22"><day>22</day><month>11</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-11-22"><day>22</day><month>11</month><year>2022</year></date></history><permissions><copyright-year>2007</copyright-year><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncohematology.abvpress.ru/ongm/article/view/614">https://oncohematology.abvpress.ru/ongm/article/view/614</self-uri><abstract xml:lang="en"><p>This is a case report of the 64-year-old male patient who suffered of previously untreated chronic lymphocytic leukemia (CLL), and paraneoplastic pemphigus. He was treated with prednisolone, MabThera, chlorambucil and cyclophosphamide. The patient achieved remission of CLL, and all symptoms of paraneoplastic pemphigus disappeared. During the year after the treatment he has good performance status, and receives only low doses of chlorambucil and prednisolone.</p></abstract><trans-abstract xml:lang="ru"><p>Приводится описание больного 64 лет с паранеопластической пузырчаткой, развившейся на фоне циклофосфаном илейкераном привело к ремиссии ХЛЛ и исчезновению всех симптомов пузырчатки. В течение года после лечения больной находится в хорошем состоянии и получает только малые дозы лейкерана и преднизолона.</p></trans-abstract><kwd-group xml:lang="en"><kwd>paraneoplastic pemphigus</kwd><kwd>CLL</kwd><kwd>prednisolone</kwd><kwd>leukeran</kwd><kwd>mabthera</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>паранеопластическая пузырчатка</kwd><kwd>ХЛЛ</kwd><kwd>преднизолон</kwd><kwd>лейкеран</kwd><kwd>мабтера</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1.	Anhalt G.J., Chan K.S., Stanley J.R. et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990;393:1729—35.</mixed-citation><mixed-citation xml:lang="ru">Anhalt G.J., Chan K.S., Stanley J.R. et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990;393:1729—35.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2.	Korman N.J., Eyre R.W., Klaus-Kovtun V., Stanly J.R. Demonstration of an adhering-junction molecule (plakoglobin) in the autoantigens of pemphigus foliacens and pemphigus vulgaris. N Engl J Med 1989;321:631 — 5.</mixed-citation><mixed-citation xml:lang="ru">Korman N.J., Eyre R.W., Klaus-Kovtun V., Stanly J.R. Demonstration of an adhering-junction molecule (plakoglobin) in the autoantigens of pemphigus foliacens and pemphigus vulgaris. N Engl J Med 1989;321:631 — 5.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3.	Ruhrberg Ch., Hajibagheri M.A.N., Parry D.A.D., Watt F.M. Periplakin, a novel component of cornified envelopes and desmosomes that belongs to the plakin family and forms complexes with envoplakin. J Cell Biology 1997;139:1835—49.</mixed-citation><mixed-citation xml:lang="ru">Ruhrberg Ch., Hajibagheri M.A.N., Parry D.A.D., Watt F.M. Periplakin, a novel component of cornified envelopes and desmosomes that belongs to the plakin family and forms complexes with envoplakin. J Cell Biology 1997;139:1835—49.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4.	Ашмарин Ю.Я., Буров Г.П., Жгун А.А. О сочетании вульгарной пузырчатки и рака желудка. Клин мед 1959;(4):142—4.</mixed-citation><mixed-citation xml:lang="ru">Ашмарин Ю.Я., Буров Г.П., Жгун А.А. О сочетании вульгарной пузырчатки и рака желудка. Клин мед 1959;(4):142—4.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5.	Потекаев Н.С., Кечкер В.И., Николаева Л.П. Злокачественные новообразования и везикуло-буллезные дерматозы. Труды 1 ММИ. Т. 31. Гистохимические и биохимические исследования в дерматологии. М.; 1964. с. 227—32.</mixed-citation><mixed-citation xml:lang="ru">Потекаев Н.С., Кечкер В.И., Николаева Л.П. Злокачественные новообразования и везикуло-буллезные дерматозы. Труды 1 ММИ. Т. 31. Гистохимические и биохимические исследования в дерматологии. М.; 1964. с. 227—32.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6.	Mahoney M.G., Aho S., Uitto J., Stanley J. The Members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin. J Invest Dermatol 1998;111:308—13.</mixed-citation><mixed-citation xml:lang="ru">Mahoney M.G., Aho S., Uitto J., Stanley J. The Members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin. J Invest Dermatol 1998;111:308—13.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7.	Amagai M., Nishikawa T., Nousari H.C. et al. Antibodies against desmoglein 3(pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantolysis in vivo in necnatal mice. J Clin Invest 1998;102:775—8.</mixed-citation><mixed-citation xml:lang="ru">Amagai M., Nishikawa T., Nousari H.C. et al. Antibodies against desmoglein 3(pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantolysis in vivo in necnatal mice. J Clin Invest 1998;102:775—8.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8.	Reich K., Brinck U., Letschart M. et al. Graft-versus host disease —like immunophenotype and apoptotic ker-atinocyte death in paraneoplastic pemphigus. Br J Dermatol 1999;141:739—46.</mixed-citation><mixed-citation xml:lang="ru">Reich K., Brinck U., Letschart M. et al. Graft-versus host disease —like immunophenotype and apoptotic ker-atinocyte death in paraneoplastic pemphigus. Br J Dermatol 1999;141:739—46.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9.	Vu Thuong N., Assane N., Bassler K. Classification, clinical manifestations, and immunopatological mechanism of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. Arch Dermatol 2001;137:193—206.</mixed-citation><mixed-citation xml:lang="ru">Vu Thuong N., Assane N., Bassler K. Classification, clinical manifestations, and immunopatological mechanism of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. Arch Dermatol 2001;137:193—206.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10.	Kim S.C., Kwon Y.D., Lee Y.J. et al. CDNA cloning of the 210 paraneoplastic pemphigus antigen revels that envoplakin is component of the antigen complex. J Invest Dermatol 1997;109:365—9.</mixed-citation><mixed-citation xml:lang="ru">Kim S.C., Kwon Y.D., Lee Y.J. et al. CDNA cloning of the 210 paraneoplastic pemphigus antigen revels that envoplakin is component of the antigen complex. J Invest Dermatol 1997;109:365—9.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11.	Mahler V., Antoni C., Anhalt G.J. et al. Graft-versus-host-like mucocutaneous eruptions with serological features of paraneoplastic pemphigus and sistemic lupus erythematosus in a patient with non-hodgrin lymphoma. Dermatology 1998;197:78—83.</mixed-citation><mixed-citation xml:lang="ru">Mahler V., Antoni C., Anhalt G.J. et al. Graft-versus-host-like mucocutaneous eruptions with serological features of paraneoplastic pemphigus and sistemic lupus erythematosus in a patient with non-hodgrin lymphoma. Dermatology 1998;197:78—83.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12.	Nousari H.C,, Deterling R., Wojtczack H. et al. The mechanism of respiratory failure in paraneoplastic pemphigus. N Tngl J Med 1999;340:1406—10.</mixed-citation><mixed-citation xml:lang="ru">Nousari H.C,, Deterling R., Wojtczack H. et al. The mechanism of respiratory failure in paraneoplastic pemphigus. N Tngl J Med 1999;340:1406—10.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13.	Wolff H., Kunte C., Messer G. et al. Paraneoplastic pemphigus with fetal pulmonary involvement in a woman with a mesenteric castleman tumor. Br J Dermatol 1999;140:313—6.</mixed-citation><mixed-citation xml:lang="ru">Wolff H., Kunte C., Messer G. et al. Paraneoplastic pemphigus with fetal pulmonary involvement in a woman with a mesenteric castleman tumor. Br J Dermatol 1999;140:313—6.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14.	Chin A.C., Stich D., White F.V. et al. Paraneoplastic pemphigus and bronchiolitis obliterans associated with a mediastinal mass: a rare case of castle-man’s disease with respiratory failure requiring lung transplantation. J Pediatric Surgery 2001;36:1—5.</mixed-citation><mixed-citation xml:lang="ru">Chin A.C., Stich D., White F.V. et al. Paraneoplastic pemphigus and bronchiolitis obliterans associated with a mediastinal mass: a rare case of castle-man’s disease with respiratory failure requiring lung transplantation. J Pediatric Surgery 2001;36:1—5.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15.	Потекаев Н.С., Теплюк Н.П., Ястребова Р.И. и др. Паранеопластическая пузырчатка в послеоперационном периоде. Росс журн кожн венерич бол 2003;(2):23—5.</mixed-citation><mixed-citation xml:lang="ru">Потекаев Н.С., Теплюк Н.П., Ястребова Р.И. и др. Паранеопластическая пузырчатка в послеоперационном периоде. Росс журн кожн венерич бол 2003;(2):23—5.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16.	Шеклаков Н.Д. Одновременное поражение пищевода пузырчаткой и раковой опухолью. Сов мед 1966;(3):122—6.</mixed-citation><mixed-citation xml:lang="ru">Шеклаков Н.Д. Одновременное поражение пищевода пузырчаткой и раковой опухолью. Сов мед 1966;(3):122—6.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17.	Теплюк Н.П. Истинная пузырчатка и буллезный пемфигоид как паранеопластические процессы. Альманах клинической медицины. Т. IX. Пролиферативные заболевания кожи. М.; 2006. с. 134—7.</mixed-citation><mixed-citation xml:lang="ru">Теплюк Н.П. Истинная пузырчатка и буллезный пемфигоид как паранеопластические процессы. Альманах клинической медицины. Т. IX. Пролиферативные заболевания кожи. М.; 2006. с. 134—7.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18.	Krumic A.L., Kokai D., Basetic B. et al. Retroperitoneal round-cell liposarcoma associated with paraneoplastic pemphigus presenting as lichen planus pemphigoidеs-Цke eruption. Int J Dermatol 1997;36:526—9.</mixed-citation><mixed-citation xml:lang="ru">Krumic A.L., Kokai D., Basetic B. et al. Retroperitoneal round-cell liposarcoma associated with paraneoplastic pemphigus presenting as lichen planus pemphigoidеs-Цke eruption. Int J Dermatol 1997;36:526—9.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19.	Anhalt G.J. Paraneoplastic pemphigus: the role of tumors and drugs. Br J Dermatol 2001;144:1101—4.</mixed-citation><mixed-citation xml:lang="ru">Anhalt G.J. Paraneoplastic pemphigus: the role of tumors and drugs. Br J Dermatol 2001;144:1101—4.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20.	Nikolskaia O.V., Nousari C.H., Anhalt G.J. Paraneoplastic pemphigus in association with castleman’s disease. Br J Dermatol 2003;149:1143—51.</mixed-citation><mixed-citation xml:lang="ru">Nikolskaia O.V., Nousari C.H., Anhalt G.J. Paraneoplastic pemphigus in association with castleman’s disease. Br J Dermatol 2003;149:1143—51.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">21.	Kaplan Y., Hodak E., Ackerman L. et al. Neoplasms associated with paraneoplastic pemphigus: a review with emphesis on non-hematologic malignancy and oral mucosal manifestation. Oral Oncol 2004;40:553—62.</mixed-citation><mixed-citation xml:lang="ru">Kaplan Y., Hodak E., Ackerman L. et al. Neoplasms associated with paraneoplastic pemphigus: a review with emphesis on non-hematologic malignancy and oral mucosal manifestation. Oral Oncol 2004;40:553—62.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">22.	Healy C.M., Thornhill M.H. An association between recurrent oro-geni-tal ulceration and non-steroidal antiinflammatory drugs. J Oral Pathol Med 1995;24:46—8.</mixed-citation><mixed-citation xml:lang="ru">Healy C.M., Thornhill M.H. An association between recurrent oro-geni-tal ulceration and non-steroidal antiinflammatory drugs. J Oral Pathol Med 1995;24:46—8.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">23.	Gooptu C., Littlewood T.J., Frith P. et al Paraneoplastic pemphigus: an association with fludarabine? Br J Dermatol 2001;144:1255—61.</mixed-citation><mixed-citation xml:lang="ru">Gooptu C., Littlewood T.J., Frith P. et al Paraneoplastic pemphigus: an association with fludarabine? Br J Dermatol 2001;144:1255—61.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">24.	Valsecchi R., Resengheti A., Cainelli A. Bullous and erosive stomatitis induced by nimesulide. Dermatology 1992;185:74—5.</mixed-citation><mixed-citation xml:lang="ru">Valsecchi R., Resengheti A., Cainelli A. Bullous and erosive stomatitis induced by nimesulide. Dermatology 1992;185:74—5.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">25.	Kirsner R.S., Anhalt G.J., Kerdel F.A. Treatment with alpha interferon associated with the development of paraneoplastic pemphigus. Br J Dermatol 1995;132:474—8.</mixed-citation><mixed-citation xml:lang="ru">Kirsner R.S., Anhalt G.J., Kerdel F.A. Treatment with alpha interferon associated with the development of paraneoplastic pemphigus. Br J Dermatol 1995;132:474—8.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">26.	Bronmmann M., von Felbert V., Streit M. et al. Progressive respiratory failure in paraneoplastic pemphigus associated with chronic lymphocytic leukemia. Dermatology 2004;208:251—4.</mixed-citation><mixed-citation xml:lang="ru">Bronmmann M., von Felbert V., Streit M. et al. Progressive respiratory failure in paraneoplastic pemphigus associated with chronic lymphocytic leukemia. Dermatology 2004;208:251—4.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">27.	Berradori L., Lombardi T., Samson J. et al. Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to cd20(+) follicular lymphoma-associated paraneoplastic pemphigus. Arch Dermatol 2001;137:269—72.</mixed-citation><mixed-citation xml:lang="ru">Berradori L., Lombardi T., Samson J. et al. Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to cd20(+) follicular lymphoma-associated paraneoplastic pemphigus. Arch Dermatol 2001;137:269—72.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">28.	Hohwy T., Bang K., Steimche T. et al. Alemtuzumab-induced remission of both severe paraneoplastic pemphigus and leukemic bone morrow infiltration in a case of treatment-resistant b-cell chronic lymphocytic leukemia. Eur J Haematol 2004;73:206—9.</mixed-citation><mixed-citation xml:lang="ru">Hohwy T., Bang K., Steimche T. et al. Alemtuzumab-induced remission of both severe paraneoplastic pemphigus and leukemic bone morrow infiltration in a case of treatment-resistant b-cell chronic lymphocytic leukemia. Eur J Haematol 2004;73:206—9.</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">29.	Camisa C., Helm T.N. Paraneoplastic pemphigus is a distinct neoplasia-induced autoimmune disease. Arch Dermatol 1993;129:883—6.</mixed-citation><mixed-citation xml:lang="ru">Camisa C., Helm T.N. Paraneoplastic pemphigus is a distinct neoplasia-induced autoimmune disease. Arch Dermatol 1993;129:883—6.</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">30.	Yuaoki M., Kodera M., Fujimoto A. et al. Paraneoplastic pemphigus without antidesmoglein 3 or antidesmoglein 1 autoantibodies. Br J Dermatol 2001;144:610—3.</mixed-citation><mixed-citation xml:lang="ru">Yuaoki M., Kodera M., Fujimoto A. et al. Paraneoplastic pemphigus without antidesmoglein 3 or antidesmoglein 1 autoantibodies. Br J Dermatol 2001;144:610—3.</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">31.	Cerroni L., Zenahlik P., Hofler G. et al. Specific cutaneous infiltrates of b-cell chronic lymphocytic leukemia. a clinicopathologic and prognostic study of 42 patients. Am J Surgical Pathol 1996;20:1000—10.</mixed-citation><mixed-citation xml:lang="ru">Cerroni L., Zenahlik P., Hofler G. et al. Specific cutaneous infiltrates of b-cell chronic lymphocytic leukemia. a clinicopathologic and prognostic study of 42 patients. Am J Surgical Pathol 1996;20:1000—10.</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">32.	Hamblin T. Autoimmune disease and its management in chronic lymphocytic leukemia. In: Chronic lymphoid leukemias. B.D. Cheson (ed). N Y, Marsel Dekker; 2001. p. 435—58.</mixed-citation><mixed-citation xml:lang="ru">Hamblin T. Autoimmune disease and its management in chronic lymphocytic leukemia. In: Chronic lymphoid leukemias. B.D. Cheson (ed). N Y, Marsel Dekker; 2001. p. 435—58.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
